CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,017 Cr | ₹853 Cr | ₹713 Cr | ₹617 Cr | ₹512 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
Year | Revenue |
---|---|
Mar2024 | ₹1,017 Cr |
Mar2023 | ₹853 Cr |
Mar2022 | ₹713 Cr |
Mar2021 | ₹617 Cr |
Mar2020 | ₹512 Cr |
How is Revenue of CONCORD BIOTECH Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,017 Cr | 19.20 | |
Mar2023 | ₹853 Cr | 19.67 | |
Mar2022 | ₹713 Cr | 15.56 | |
Mar2021 | ₹617 Cr | 20.42 | |
Mar2020 | ₹512 Cr | - |
Compare Revenue of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹16,104.7 Cr | 7.1% | -7.4% | -2.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 7.1% |
-7.4% |
-2.7% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses